Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Oct 1;29(5):310-315.
doi: 10.1097/MOT.0000000000001165. Epub 2024 Aug 5.

Mechanical circulatory support devices in adults with congenital heart disease

Deen L Garba  1 , Susan Joseph  2 , Ari Cedars  1
Affiliations
Review

Mechanical circulatory support devices in adults with congenital heart disease

Deen L Garba et al. Curr Opin Organ Transplant. .

Abstract

Purpose of review: Mechanical circulatory support is used frequently as a method of stabilizing patients with end stage heart failure who are unable to safely await allograft availability. While this technology has been fundamentally important in supporting patients with normal cardiac anatomy, it is still used infrequently in adult patients with congenital heart disease and end-stage heart failure. Here, we review the data on mechanical circulatory support technology in this small but growing population of patients with chronic heart disease prone to the development of circulatory failure.

Recent findings: Mechanical circulatory support (MCS) has been increasingly employed in adults with congenital heart disease (ACHD) as a bridge to transplant. The new United Network for Organ Sharing listing system favoring temporary MCS use with a higher listing status offers another tool to stabilize ACHD patients and potentially shorten wait times. Both temporary and Durable MCS could help improve transplant candidacy and posttransplant outcomes in select groups of ACHD patients.

Summary: Durable and temporary MCS have the potential to significantly improve access to transplant and overall transplant outcomes in ACHD patients.

PubMed Disclaimer

References

    1. Müller MJ, Norozi K, Caroline J, Sedlak N, et al. Morbidity and mortality in adults with congenital heart defects in the third and fourth life decade. Clin Res Cardiol 2022; 111:900–911.
    1. Burchill LJ, Gao L, Kovacs AH, Opotowsky AR, et al. Hospitalization trends and health resource use for adult congenital heart disease-related heart failure. J Am Heart Assoc 2018; 7:e008775.
    1. Agasthi P, Van Houten HK, Yao X, Jain CC, et al. Mortality and morbidity of heart failure hospitalization in adult patients with congenital heart disease. J Am Heart Assoc 2023; 12:e030649.
    1. Alshawabkeh LI, Hu N, Carter KD, Opotowsky AR, et al. Wait-list outcomes for adults with congenital heart disease listed for heart transplantation in the U.S. J Am Coll Cardiol 2016; 68:908–917.
    1. Bravo-Jaimes K, Axsom K, Menachem J, Danford D, et al. Impact of the new UNOS donor heart allocation system on waitlist outcomes and early posttransplant mortality among adults with congenital heart disease. Am J Transplant 2022; 22:1123–1132.